Zhihua Xu

Dr. Zhihua Xu

Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
ZXZhihua Xu
Zhihua Xu
LSLingling Sun
Lingling Sun
YDYang Duan
Yang Duan
JZJinghua Zhang
Jinghua Zhang
MZMengzhi Zhang
Mengzhi Zhang
XCXiaonan Cai
Xiaonan Cai

1 June 2020 in Clinical Radiology
Verified
Journal Article
Closed access
JWJ. Wang
J. Wang
ZXZhihua Xu
Zhihua Xu
RFR. Feng
R. Feng
YAY. An
Y. An
WAW. Ao
W. Ao
ZXZongyu Xie
Zongyu Xie

1 December 2020 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
ZXZhihua Xu
Zhihua Xu
FLFangfei Li
Fangfei Li
BWBing Wang
Bing Wang
DXDengxiang Xing
Dengxiang Xing
YPYusong Pei
Yusong Pei
YDYang Duan
Yang Duan
Objective: To assess the suitability of deep medullary vein visibility in susceptibility weighted imaging—magnetic resonance imaging studies as a method for the diagnosis and evaluation of cerebral small vessel disease progression.Methods: A total of 92 patients with CSVD were enrolled and baseline clinical and imaging data were reviewed retrospectively. Neuroimaging biomarkers of CSVD including high-grade white matter hyperintensity (HWMH), cerebral microbleed (CMB), enlarged perivascular space (PVS), and lacunar infarct (LI) were identified and CSVD burden was calculated. Cases were grouped accordingly as mild, moderate, or severe. The DMV was divided into six segments according to the regional anatomy. The total DMV score (0–18) was calculated as the sum of the six individual segmental scores, which ranged from 0 to 3, for a semi-quantitative assessment of the DMV based on segmental continuity and visibility.Results: The DMV score was independently associated with the presence of HWMH, PVS, and LI (P < 0.05), but not with presence and absence of CMB (P > 0.05). Correlation between the DMV score and the CSVD burden was significant (P < 0.05) [OR 95% C.I., 1.227 (1.096–1.388)].Conclusion: The DMV score was associated with the presence and severity of CSVD.

25 October 2021 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
ZXZhihua Xu
Zhihua Xu
FLFangfei Li
Fangfei Li
DXDengxiang Xing
Dengxiang Xing
HSHongyan Song
Hongyan Song
JCJingshu Chen
Jingshu Chen
ZWZhenguo Wang
Zhenguo Wang
Objective: To explore the biomarkers of cerebral small vessel disease (CSVD) associated with cognitive impairment.Methods: A total of 69 patients with CSVD were enrolled in the study, and baseline clinical and imaging data were reviewed retrospectively. The following neuroimaging biomarkers of CSVD were identified: high-grade white matter hyperintensity (HWMH), cerebral microbleeds (CMB), enlarged perivascular space (PVS), and lacunar infarct (LI). A total score for CSVD was calculated. The deep medullary veins (DMVs) were divided into six segments according to the regional anatomy. The total DMV score (0–18) was derived from the sum of the scores of the six individual segments, the scores of which ranged from 0 to 3, for a semiquantitative assessment of the DMV that was based on segmental continuity and visibility.Results: The DMV score, patient age, and total CSVD score were independently associated with the presence or absence of cognitive impairment in patients with CSVD (P < 0.05). By integrating patient age and the total CSVD and DMV scores, the area under the curve of the receiver operating characteristic curve (AUROC) for predicting CSVD associated with cognitive impairment was 0.885, and the sensitivity and specificity were 64.71 and 94.23%, respectively.Conclusions: The DMV score may be a novel imaging biomarker for CSVD associated with cognitive impairment. The integration of the DMV score with age and total CSVD score should increase the predictive value of the DMV score for CSVD associated with cognitive impairment.

5 December 2019 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
ZXZhihua Xu
Zhihua Xu
YDYang Duan
Yang Duan
ZWZhenguo Wang
Zhenguo Wang
XHXin Huang
Xin Huang
YPYusong Pei
Yusong Pei
XLXiaoqiu Li
Xiaoqiu Li
Objective: To explore the relationships of asymmetric deep medullary veins (ADMV) to asymmetric cortical veins (ACV), leptomeningeal collaterals and prognosis in patients with occlusion of a large cerebral artery. Methods: Clinical and imaging data of 56 patients with occlusion of a large cerebral artery were collected and reviewed. We assessed the time delayed between stroke onset and MR imaging (within 24 h of stroke onset), extension of cerebral infarction using the Alberta stroke program early CT score based on diffusion-weighted imaging (ASPECTs). ADMV and ACV were assessed using susceptibility-weighted imaging. The presence of ADMV (ACV) was defined as deep medullary veins (cortical veins) of the affected hemisphere that were greater in number and diameter than in the contralateral hemisphere. To evaluate leptomeningeal collaterals, the hyperintense vessel sign (HVS) was detected using T2 weighted fluid attenuated inversion recovery images. At 90 days, a modified Rankin scale score (mRS) was assessed to evaluate the clinical outcome. Results: Of 56 patients, 27 presented with ADMV. Those patients who presented with and without ADMV differed significantly in HVS and ACV (P < 0.05) but not in time delayed between stroke onset and MR imaging, age, gender, stroke risk factors, baseline NIHSS score, or modified Rankin scale score at 3 months (P > 0.05). Logistic regression analysis found that the presence of ADMV was independently related to HVS and ACV (ACV: OR 95% C.I., 1.287–4.368; HVS: OR 95% C.I., 1.132–4.887). Conclusions: The presence of ADMV on SWI was associated with prominent ACV and good leptomeningeal collateral flow but was not related to prognosis in patients with occlusion of a large cerebral artery.

25 January 2022 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
HSHengfeng Shi
Hengfeng Shi
ZXZhihua Xu
Zhihua Xu
GCGuohua Cheng
Guohua Cheng
Hongli JiHongli Ji
Hongli Ji
LHLinyang He
Linyang He
JWJian Wang
Jian Wang
Background: The coronavirus disease 2019 (COVID-19) is a pandemic now, and the severity of COVID-19 determines the management, treatment, and even prognosis. We aim to develop and validate a radiomics nomogram for identifying patients with severe COVID-19. Methods: There were 156 and 104 patients with COVID-19 enrolled in primary and validation cohorts, respectively. Radiomics features were extracted from chest CT images. Least absolute shrinkage and selection operator (LASSO) method was used for feature selection and radiomics signature building. Multivariable logistic regression analysis was used to develop a predictive model, and the radiomics signature, abnormal WBC counts, and comorbidity were incorporated and presented as a radiomics nomogram. The performance of the nomogram was assessed through its calibration, discrimination, and clinical usefulness. Results: The radiomics signature consisting of four selected features was significantly associated with clinical condition of patients with COVID-19 in the primary and validation cohorts (P < 0.001). The radiomics nomogram including radiomics signature, comorbidity and abnormal WBC counts showed good discrimination of severe COVID-19, with an AUC of 0.972, and good calibration in the primary cohort. Application of the nomogram in the validation cohort still gave good discrimination with an AUC of 0.978 and good calibration. Decision curve analysis demonstrated that the radiomics nomogram was clinically useful to identify the severe COVID-19. Conclusion: We present an easy-to-use radiomics nomogram to identify the patients with severe COVID-19 for better guiding a prompt management and treatment.